Search

Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Community Bulletin for the LGMD 2B/R2 Community
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments
Sarepta Therapeutics Launches Inaugural LGMD Grant Award Program
Sarepta Therapeutics lanza el programa inaugural de concesión de subvenciones para la LGMD
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Sarepta Therapeutics Appoints Michael Chambers and Kathryn Boor, Ph.D., to Its Board of Directors